StockData

Oaktree Acquisition Corp. III Life Sciences (OACC) company profile

OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.72+0.02 (+0.19%)

Close on Nov 17, 2026Market cap $263.53MP/E –Yield –

About Oaktree Acquisition Corp. III Life Sciences

Blank Checks, SIC 6770

Oaktree Acquisition Corp. III Life Sciences is a blank check company established to execute a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The entity focuses its acquisition efforts primarily on companies within the healthcare and healthcare-related industries, with particular interest in biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors. Because the company has not yet consummated a transaction, it does not currently provide commercial products or services to external customers.

The company operates as a Cayman Islands exempted entity without active commercial operations or dedicated store footprints. It directs its target search primarily toward enterprises located in North America, the United Kingdom, and Western Europe. Its organizational activities and strategic initiatives are supported through its affiliation with Oaktree Capital, an investment management firm headquartered in Los Angeles, California.

Summary of the business section of Oaktree Acquisition Corp. III Life Sciences's latest annual report, written by StockData.

Company profile

Company

Legal name
Oaktree Acquisition Corp. III Life Sciences
Founded
2024
Headquarters
Los Angeles, CA
Address
333 South Grand Avenue, 28th Floor 90071
Phone
(213) 830-6300
Employees
1,500, Dec 31, 2025
Industry
Blank Checks
Incorporated in
E9
Fiscal year ends
December 31
Auditor
WithumSmith+Brown, PC, New York, New York

Stock & identifiers

Ticker
OACC
Other tickers
OACCU, OACCW
Exchange
Nasdaq
IPO date
Oct 24, 2024
Shares outstanding
25M, Aug 12, 2026
Public float
$200.63M, Dec 31, 2025
Filer category
<br>Emerging growth company
SEC CIK
2029769
FIGI
BBG00Z9CKF55
Share class FIGI
BBG00Z9CKG26
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
George Arthur MartinezChief Financial Officer–
Thomas SweeneyChief Financial Officer–
David A. BerryDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Oct 24, 2024
Offer price
$10.00
Securities offered
17,500,000
Gross proceeds
$175.00M
First trading day
Oct 24, 2024
First-day close
$10.000.0%
Lock-up ends (est.)
Apr 22, 2025

“Each unit has an offering price of $10.00 and consists of one Class A ordinary share, par value $0.0001 and one-fifth of one redeemable warrant.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“Oaktree is a leading global investment management firm founded in 1995 and headquartered in Los Angeles, California, with over 1,500 employees throughout offices in 26 cities in 18 countries (including offices of affiliates of Oaktree-managed funds).”

Corporate history

Events identified from SEC filings

See a number that looks wrong?